The Health Transparency Initiative builds open-source tools that make pharmaceutical industry payments to healthcare professionals searchable, cross-referenced, and usable by patients, journalists, and researchers.
All tools are open source. All datasets are free.
Marta is 41. She has rheumatoid arthritis. Each time her rheumatologist changed her prescription, the new drug cost more. Each time, he said it was "the latest evidence."
What Marta did not know: her rheumatologist received EUR 47,000 from the manufacturer of the third drug last year. Speaking fees. Advisory boards. Travel.
The payments are disclosed somewhere in a 900-page PDF on a pharmaceutical industry website, buried in a table that requires specialist knowledge to decode.
The information is technically public. It is not practically accessible. Not to Marta. Not to the journalist investigating prescribing patterns in her region. Not to the health committee member drafting policy on conflicts of interest.
All names in programme descriptions are composites representing real situations. No real names are used without written consent.
The database does not make accusations. It makes information findable. What patients, journalists, researchers, and legislators do with that information is up to them.
An open-source database that collects, structures, and cross-references pharmaceutical industry payments to healthcare professionals across European countries. EFPIA disclosure reports, parsed and searchable. National transparency registers, linked.
When conflict-of-interest declarations say "no conflicts" but the payment data says EUR 47,000, the database shows the gap. Automatically.
In countries where disclosure is incomplete, patients and journalists can file structured access requests using GDPR Article 15 and national freedom-of-information laws. Ready-to-use templates, translated and legally reviewed.
TEEI has already filed 12+ systematic GDPR requests against health institutions and documented the results.
Conflict-of-interest declarations from hospital boards and medical societies, compared against payment records. Automated monitoring that catches new disclosure publications the week they appear.
The methodology, the analysis pipelines, and the results are all published openly. Anyone can verify, replicate, or extend the work.
The Health Transparency Initiative applies the CRPD+GDPR methodology developed under the Health Equity programme. GDPR provides the legal mechanism to access data. CRPD provides the rights framework that makes data access a matter of equality.
Right of access. Any person can request a copy of personal data held about them, including data held by healthcare institutions and pharmaceutical companies.
European pharmaceutical companies are required to disclose payments to healthcare professionals. The disclosures exist. The problem is format, fragmentation, and findability.
Freedom-of-information legislation varies by country. The request templates account for national differences and provide country-specific filing instructions.
Health information must be accessible. Patients have the right to information in formats they can use. These are not aspirations. They are obligations.
Every tool is open source. Every dataset is free.
The database, the cross-referencing methodology, the request templates, the analysis pipelines. Built so that any patient, journalist, or researcher can use them without permission or payment.
The Health Transparency Initiative is part of the Health Equity programme operated by The Educational Equality Institute. All programmes are free. All tools are open source.